NYSE: BIOBio Rad Laboratories Revenue
Bio Rad Laboratories revenue was $2.56B for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $653.0M, up 0.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BIO annual revenue was $2.6B, with -3.9% growth year-over-year.
BIO past revenue growth
How has BIO's revenue growth performed historically?
Company
-0.88%
Industry
10.96%
Market
20.18%
BIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
BIO revenue history
Current Revenue
$2.6B
Current Earnings
-$675.9M
Current Profit Margin
-26.4%
Be the first to know when BIO announces revenue.
BIO Revenue History By Year
| BIO Yearly Revenue | BIO Revenue | BIO Change | BIO Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $2.57B | -$104.70M | -3.92% |
| 2023-12-31 | $2.67B | -$131.00M | -4.67% |
| 2022-12-31 | $2.80B | -$120.35M | -4.12% |
| 2021-12-31 | $2.92B | $376.92M | +14.81% |
| 2020-12-31 | $2.55B | $233.97M | +10.12% |
| 2019-12-31 | $2.31B | $22.24M | +0.97% |
| 2018-12-31 | $2.29B | $129.26M | +5.98% |
| 2017-12-31 | $2.16B | $91.98M | +4.45% |
| 2016-12-31 | $2.07B | $48.73M | +2.41% |
| 2015-12-31 | $2.02B | -$155.60M | -7.15% |
| 2014-12-31 | $2.18B | $42.35M | +1.99% |
| 2013-12-31 | $2.13B | $63.46M | +3.07% |
| 2012-12-31 | $2.07B | -$4.29M | -0.21% |
| 2011-12-31 | $2.07B | $146.41M | +7.60% |
| 2010-12-31 | $1.93B | $142.87M | +8.01% |
| 2009-12-31 | $1.78B | $19.88M | +1.13% |
| 2008-12-31 | $1.76B | $303.31M | +20.76% |
| 2007-12-31 | $1.46B | $187.12M | +14.69% |
| 2006-12-31 | $1.27B | $92.95M | +7.87% |
| 2005-12-31 | $1.18B | $90.97M | +8.35% |
| 2004-12-31 | $1.09B | $110.38M | +11.27% |
| 2003-12-31 | $979.63M | $114.63M | +13.25% |
| 2002-12-31 | $865.01M | $47.50M | +5.81% |
| 2001-12-31 | $817.51M | $91.63M | +12.62% |
| 2000-12-31 | $725.88M | $170.49M | +30.70% |
| 1999-12-31 | $555.40M | $107.54M | +24.01% |
| 1998-12-31 | $447.86M | $20.95M | +4.91% |
| 1997-12-31 | $426.91M | $8.13M | +1.94% |
| 1996-12-31 | $418.79M | $22.17M | +5.59% |
| 1995-12-31 | $396.62M | $41.32M | +11.63% |
| 1994-12-31 | $355.30M | $26.75M | +8.14% |
| 1993-12-31 | $328.55M | -$1.75M | -0.53% |
| 1992-12-31 | $330.30M | N/A | N/A |
Bio Rad Laboratories Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.